With great interest we read the editorial ‘‘Expanding Indications of Recombinant Human TSH (rhTSH) in Thyroid Cancer’’ (1), which considered the extensive worldwide clinical experience with rhTSH. It is a very interesting review; however, we would like to clarify several points regarding the use of rhTSH in Argentina. Thyrogen has been used in Argentina for 7 years, and we have published and pr...

On the territory of Russia has increased thyroid cancer after Chernobyl NPP incidence at 1986, and currently accounts for up to 14,000 newly identified cases. Postoperative radioiodine (RAI) remnant ablation is second stage combine treatment differentiated cancer, except prevalence pT 1 N 0 M , with minimal level TG AT-TG, according international guidelines. In past 20 years a significant numbe...

background: the therapeutic administration of 131i for thyroid remnant ablation and for metastases comes up with some adverse effects. this study was conducted to investigate whether single high dose radioiodine therapy affects lacrimal gland functions or not. materials and methods: seventy-eight eyes of 39 patients, who were diagnosed as differentiated thyroid carcinoma, were objectively teste...

To supplement limited relevant literature, we retrospectively compared ablation and disease outcomes in high-risk differentiated thyroid carcinoma (DTC) patients undergoing radioiodine thyroid remnant ablation aided by recombinant human thyrotropin (rhTSH) versus thyroid hormone withdrawal/withholding (THW). Our cohort was 45 consecutive antithyroglobulin antibody- (TgAb-) negative, T3-T4/N0-N1...

BACKGROUND AND PURPOSE No study has previously examined the feasibility of using EA to remove any peripherally located, solid components remaining after treatment of benign solid thyroid nodules by RFA. The aim of this study was to assess the efficacy of EA in removing remnant solid components following the incomplete ablation of benign solid thyroid nodules by RFA. MATERIALS AND METHODS Duri...

Anaplastic thyroid carcinoma (ATC) is an aggressive malignancy and characterized by spreading to regional lymph nodes and distant metastases, but we were unable to find a previous report of simultaneous metastases of transformed ATC to either the small intestine or thoracic esophagus in the English language literature. A 60-year-old man suffered from well-differentiated thyroid carcinoma and un...

Radioactive iodine is utilized commonly for ablation of remnant thyroid tissue after thyroidectomy and treatment of persistent disease and metastases in differentiated thyroid cancer patients. As it involves ionizing radiation, it is important to ensure that the patients receive optimum amount of radiation to destruct the target tissue while keeping the radiation-related side effects to minimum...

The long-term monitoring of patients with differentiated thyroid carcinoma (DTC) is essential throughout the patient's life after total or near-total thyroidectomy followed by (131)I remnant ablation and thyroid hormone suppression of thyroid-stimulating hormone (TSH). Sensitive surveillance for DTC recurrence and metastases includes radioiodine diagnostic whole-body scanning (DWBS) and measure...